Lessons learnt from implementing change in newborn bloodspot screening processes over more than a decade: Midwives, genetics and education.


Journal

Midwifery
ISSN: 1532-3099
Titre abrégé: Midwifery
Pays: Scotland
ID NLM: 8510930

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 08 03 2019
revised: 09 08 2019
accepted: 21 09 2019
pubmed: 1 10 2019
medline: 21 4 2020
entrez: 1 10 2019
Statut: ppublish

Résumé

To explore midwives' roles and education requirements in newborn bloodspot screening (NBS) for genetic conditions, as programs and supporting education evolve over time. NBS processes are evolving and will continue to evolve with new genetic and genomic technologies. Midwives have a critical role in facilitating NBS, as they are the primary healthcare professional to interact with parents at the time of collecting the bloodspot. As new consent processes and genomic technologies are incorporated into NBS, midwives need to stay up-to-date with these changes, so that parents can make an informed decision about having the test and future use of the DNA sample. We used a cross-sectional approach to analyse midwives' knowledge and behaviour in 2005/6 and 2016, with changes in NBS processes and education introduced in 2011. We found midwives' NBS knowledge improved in 8/18 areas after a 10-year period, mostly related to process changes, but there was also an increase in misconceptions regarding which conditions are screened. Areas of significant improvement were not consistently explained by participation in continuing professional development (CPD). We found midwives used official brochures and NBS collection cards to guide discussions with families. Changes to the NBS collection cards, together with the content of CPD materials, aligned with the significant improvements and deficits we observed. When considering potential changes to future maternity care that incorporates emerging genomic technologies, midwives indicated the main barrier was their lack of knowledge; the majority (60.3%) reported supervision support to attend genomics CPD. Changes in NBS practice should be implemented through multifaceted programs that include education sessions and procedural prompts. The NBS collection card should be seen not just as a legal consent document but also as an educational tool. As NBS programs evolve through the addition of conditions screened for or changes to technology or consent processes, multiple strategies should be applied to upskill midwives to ensure they can best support parents to make informed choices.

Sections du résumé

OBJECTIVE OBJECTIVE
To explore midwives' roles and education requirements in newborn bloodspot screening (NBS) for genetic conditions, as programs and supporting education evolve over time.
BACKGROUND BACKGROUND
NBS processes are evolving and will continue to evolve with new genetic and genomic technologies. Midwives have a critical role in facilitating NBS, as they are the primary healthcare professional to interact with parents at the time of collecting the bloodspot. As new consent processes and genomic technologies are incorporated into NBS, midwives need to stay up-to-date with these changes, so that parents can make an informed decision about having the test and future use of the DNA sample.
RESEARCH DESIGN/SETTING METHODS
We used a cross-sectional approach to analyse midwives' knowledge and behaviour in 2005/6 and 2016, with changes in NBS processes and education introduced in 2011.
FINDINGS RESULTS
We found midwives' NBS knowledge improved in 8/18 areas after a 10-year period, mostly related to process changes, but there was also an increase in misconceptions regarding which conditions are screened. Areas of significant improvement were not consistently explained by participation in continuing professional development (CPD). We found midwives used official brochures and NBS collection cards to guide discussions with families. Changes to the NBS collection cards, together with the content of CPD materials, aligned with the significant improvements and deficits we observed. When considering potential changes to future maternity care that incorporates emerging genomic technologies, midwives indicated the main barrier was their lack of knowledge; the majority (60.3%) reported supervision support to attend genomics CPD.
KEY CONCLUSIONS CONCLUSIONS
Changes in NBS practice should be implemented through multifaceted programs that include education sessions and procedural prompts. The NBS collection card should be seen not just as a legal consent document but also as an educational tool.
IMPLICATIONS FOR PRACTICE CONCLUSIONS
As NBS programs evolve through the addition of conditions screened for or changes to technology or consent processes, multiple strategies should be applied to upskill midwives to ensure they can best support parents to make informed choices.

Identifiants

pubmed: 31569029
pii: S0266-6138(19)30234-7
doi: 10.1016/j.midw.2019.102542
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102542

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Auteurs

Amy Nisselle (A)

Murdoch Children's Research Institute, Flemington Rd, Parkville, VIC 3052, Australia; The University of Melbourne, Parkville, VIC 3052, Australia. Electronic address: amy.nisselle@mcri.edu.au.

Michelle Bishop (M)

Genomics Education Program, Health Education England, Hagley Road, Birmingham B16 9RG, United Kingdom. Electronic address: michelle.bishop@hee.nhs.uk.

Taryn Charles (T)

Murdoch Children's Research Institute, Flemington Rd, Parkville, VIC 3052, Australia; The University of Melbourne, Parkville, VIC 3052, Australia; Victorian Clinical Genetics Services, Flemington Rd, Parkville, VIC 3052, Australia. Electronic address: taryn.charles@vcgs.org.au.

Sally Morrissy (S)

Victorian Clinical Genetics Services, Flemington Rd, Parkville, VIC 3052, Australia. Electronic address: sally.morrissy@vcgs.org.au.

Emily King (E)

Murdoch Children's Research Institute, Flemington Rd, Parkville, VIC 3052, Australia; The University of Melbourne, Parkville, VIC 3052, Australia. Electronic address: emily.king@mcri.edu.au.

Sylvia Metcalfe (S)

Murdoch Children's Research Institute, Flemington Rd, Parkville, VIC 3052, Australia; The University of Melbourne, Parkville, VIC 3052, Australia. Electronic address: sylvia.metcalfe@mcri.edu.au.

Clara Gaff (C)

Murdoch Children's Research Institute, Flemington Rd, Parkville, VIC 3052, Australia; The University of Melbourne, Parkville, VIC 3052, Australia; Walter & Eliza Hall Institute of Medical Research, Royal Parade, Parkville, VIC 3052, Australia. Electronic address: cgaff@unimelb.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH